Claire Skentelbery’s Post

The 26th edition of the Guide to German Biotech Companies is out now! 🎉 Explore profiles of over 100 #biotech companies—from innovative startups to global leaders—across 240 vibrant pages. This guide is your go-to resource for discovering Germany's biotech sector in English, highlighting firms focused on #ResearchAndDevelopment and those with a global impact. 📊 Plus, dive into the core findings of the latest BIOCOM industry statistics on biotechnology in Germany. Get your copy today! https://lnkd.in/eTmAf2Ws #Biotechnologie #Germany #BiotechGuide #Innovation #BIOCOM

Biotechnology in Europe: 1) Europe's biotech renaissance by Melanie Senior. Open access: https://lnkd.in/dMPBhFAF 2) European biotech financing is maturing but the gap with the US keeps growing (2019) by Franck Le Deu and Jorge Santos da Silva https://lnkd.in/dY_HfM8m 3) Europe’s potential for biotech innovation (2019) https://lnkd.in/d3MCvqP8 Further readings: 1) Bridging the gap between innovation and later-stage financing for biotech in Europe (2023) https://lnkd.in/d2Nstx4z 2) International VC funding https://lnkd.in/gaKCwDBR 3) Infographic: Biotech hot spots in a fragmented European landscape (2021) https://lnkd.in/d9FK6C_U 4) Building European biotech sector with world-class science and innovation (2021) https://lnkd.in/dDgTGuww 5) The rise of venture capital in Europe https://lnkd.in/dnz5bQvM

The biotech industry stands at a pivotal moment, facing both significant challenges and remarkable opportunities. Economic headwinds and declining venture capital have created hurdles, but the sector's resilience is evident through continued innovation and strategic advancements. Key drivers include government initiatives like ARPA-H and the CHIPS and Science Act, which are providing crucial support. Additionally, the expansion of lab spaces and focused workforce development are laying the groundwork for future growth. The industry's progress, despite these headwinds, highlights its adaptability and potential for continued innovation. For a deeper dive, explore the full article: https://bit.ly/4cJpVEA #biotech #lifesciences #workforcedevelopment

🚀 Charles River Launches Biotech Incubator Program 🧫Charles River Laboratories unveils a biotech incubator program to foster innovation and accelerate early-stage research breakthroughs. Know complete story: https://lnkd.in/d3u3AHXk #PharmaNews #BiotechInnovation #ResearchDevelopment #HealthcareAdvancements #PharmaceuticalIndustry Dawn Joha Smitha Gawde, Ph.D.

The biotech revolution starts with YOU! 🌱💡 Choosing the right university is key to turning your passion into innovation. Ready to explore the world of biotech? Let’s discuss your top picks! 🌍🔬 #BiotechEducation #InnovatorsInTheMaking

🌟 The time for European Biotechnology is now! 🌟 EuropaBio - the European Association for Bioindustries, has unveiled a bold vision for #EUBiotechAct! 🧬💙 This visionary paper advocates for the Act aimed at strengthening value chains from R&D to end-users, creating coherent regulatory pathways, bolstering IP, and fostering a next-generation biotech ecosystem, which will contribute to the increase of the #EUCompetitiveness. The EU Biotech Act represents Europe's opportunity to establish a cornerstone for this strategically critical technology. A robust Biotech Act will send a global signal that our innovation and capacity will support healthy citizens, competitive sectors, and a sustainable future. Let's champion this cause! 💪🌍 #Biotech #Innovation #AccessToInnovation 

Explore how biotechs can unlock early value in their commercial journey and look ahead to a brighter future at the 2024 Fierce Biotech Summit. Don’t miss our presentation in the Strategy and Dealmaking track at 2:30pm on September 30. #commercialsuccess #biotech #innovation Karla Anderson, Maya K. Desai, PhD, Michele Fuller

“In order to make it easier to bring biotech from the laboratory to factory and then onto the market we will propose a new European Biotech Act in 2025.” In her Strategic Plan for the next 5 years, the President of the European Commission, Ursula von der Leyen, confirmed her determination to strengthen the competitiveness of the biotechnology sector in Europe. The European Biotech Act is a strong commitment by the Commission and the Member States to defend our technological leadership and ensure that our ecosystem is not held back in its promising development. Belgium's priorities for the Biotech Act are clear: to simplify European regulations to speed up the time-to-market for innovative products, to ensure the financing of innovation and production projects through fund-raising capacities comparable to those in the United States or Asia, and finally, to encourage Europe-wide collaboration around facilitating tools such as incubators, bioclusters, digitisation of production tools, etc. Over the last few decades, Belgium has forged an internationally recognised reputation for excellence in the life sciences sector. The Biotech Act will need to define a framework that will enable it to maintain this excellence. Tineke Van hooland Pio PETER Jerome Van Biervliet Luc Debruyne Marc Dechamps Skander Nasra Thomas Van Cangh EuropaBio - the European Association for Bioindustries Claire Skentelbery Dr Anne-Gaelle Collot Adrien Samson José P. bio.be/essenscia

Have you read our latest article written by Biotech expert Dr Dan Sheridan? 📣 In the fast-paced world of biotech, scientific breakthroughs are exciting, but turning a novel discovery into a commercial success requires a strategic approach that goes beyond the lab. 🔬 In the article "Beyond the Lab: Essential Biotech Marketing Strategies for Startup Success." Dr Dan Sheridan dives deep into early-stage biotech companies' challenges and provides actionable strategies to overcome them. 🔗 Read the article here: https://lnkd.in/dkgCpiSk #biotechnology #biotech #lifescience #bioscience #biopharma #biotechstartups #transformingscienceintostory #lifesciences #article #blog #thoughtleadership  #beyondthelab #strategy #biotechstartup

🌟 Advanced Therapies Week Highlight: Launch of Charles River's Global Biotech Incubator Program 🌟 Join Kerstin Dolph, Senior VP of Manufacturing at Charles River Laboratories, and host Benjamin McLeod from Convey Bio for an exciting introduction to the Charles River Incubator Program (CIP). This pioneering program supports the journey of early-stage biotechnology companies in the development of advanced therapies. The CIP is dedicated to nurturing startups by offering regulatory guidance, quality expertise, personnel training, and access to laboratory facilities, all aimed at enhancing their path to commercial success. Discover how your biotech venture can apply and benefit from this unique opportunity to accelerate growth and innovation. #AdvancedTherapiesWeek #ATW25 #AdvancedTherapies #CharlesRiver #BiotechIncubator